8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
May 1, 2026·SEC
Material company update
Feb 2, 2026·SEC
Revvity, Inc.(RVTY)Earnings, Financials & Key Ratios
RVTY•NYSE
48.1× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryDiagnostics & ResearchSub-IndustryLife Science Instruments and Sequencing Tools
AboutRevvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.Show more
- Revenue$2.86B+3.7%
- EBITDA$659M-21.4%
- Net Income$242M-18.3%
- EPS (Diluted)2.08-13.7%
- Gross Margin53.08%+10.6%
- EBITDA Margin23.07%-24.2%
- Operating Margin12.49%-16.2%
- Net Margin8.46%-21.2%
- ROE3.24%-14.9%
RVTY Key Insights
Revvity, Inc. (RVTY) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓FCF machine: 17.8% free cash flow margin
- ✓High quality earnings: Operating CF exceeds net income
- ✓Share count reduced 7.8% through buybacks
- ✓Healthy 5Y average net margin of 11.3%
✗Weaknesses
- ✗Weak 3Y average ROE of 1.8%
- ✗Profits declining 19.8% over 5 years
- ✗Sales declining 5.5% over 5 years
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when RVTY posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
RVTY Price & Volume
Revvity, Inc. (RVTY) stock price & volume — 10-year historical chart
Loading chart...
RVTY Growth Metrics
Revvity, Inc. (RVTY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years3.1%
5 Years-5.47%
3 Years-4.82%
TTM4.78%
Profit CAGR
10 Years1.3%
5 Years-19.79%
3 Years-24.84%
TTM-22.36%
EPS CAGR
10 Years1.04%
5 Years-20.37%
3 Years-22.69%
TTM-16.97%
Return on Capital
10 Years7.58%
5 Years5.82%
3 Years3.28%
Last Year3.16%
RVTY Recent Earnings
Revvity, Inc. (RVTY) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 5, 2026Metric
Actual
Est
EPS
$1.06+3.9%
$1.02
Rev
$711M+1.0%
$704M
Q1 2026
Feb 2, 2026Metric
Actual
Est
EPS
$1.70+8.3%
$1.57
Rev
$772M+0.9%
$765M
Q4 2025
Oct 27, 2025Metric
Actual
Est
EPS
$1.18+3.5%
$1.14
Rev
$699M-0.1%
$699M
Q3 2025
Jul 28, 2025Metric
Actual
Est
EPS
$1.18+3.5%
$1.14
Rev
$720M+2.9%
$700M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $1.06vs $1.02+3.9% | $711Mvs $704M+1.0% |
| Q1 2026 | Feb 2, 2026 | $1.70vs $1.57+8.3% | $772Mvs $765M+0.9% |
| Q4 2025 | Oct 27, 2025 | $1.18vs $1.14+3.5% | $699Mvs $699M-0.1% |
| Q3 2025 | Jul 28, 2025 | $1.18vs $1.14+3.5% | $720Mvs $700M+2.9% |
Based on last 12 quarters of dataView full earnings history →
RVTY Peer Comparison
Revvity, Inc. (RVTY) competitors in Life Science Instruments and Sequencing Tools — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 WAT | 23.17B | 355.44 | 33.03 | 6.99% | 11.91% | 8.04% | 0.55 | |
 BRKR | 8.71B | 57.23 | -381.53 | 2.08% | -0.34% | -0.5% | 0.81 | |
 MTD | 23.13B | 1144.84 | 27.15 | 3.98% | 21.4% | |||
 BIO | 7.63B | 282.44 | 10.13 | 0.65% | 6.52% | 2.4% | 0.21 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 | |
 TMO | 172.66B | 464.61 | 26.19 | 3.91% | 15.18% | 13.23% | 0.76 | |
 DHR | 125.4B | 177.17 | 35.15 | 2.9% | 14.89% | 7.06% | 0.35 | |
 A | 35.89B | 127.06 | 27.80 | 6.73% | 19.55% | 20.84% | 0.50 |
Compare RVTY vs Peers
Revvity, Inc. (RVTY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
RVTY Income Statement
Revvity, Inc. (RVTY) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 2.26B | 2.78B | 2.88B | 3.78B | 3.83B | 3.31B | 2.75B | 2.76B | 2.86B | 2.9B |
Revenue Growth % | 6.69% | 23.08% | 3.8% | 31.18% | 1.19% | -13.48% | -16.95% | 0.16% | 3.67% | 4.78% |
Cost of Goods Sold | 1.23B | 1.53B | 1.59B | 1.79B | 1.55B | 1.55B | 1.43B | 1.43B | 1.34B | 1.41B |
COGS % of Revenue | 54.39% | 54.96% | 55.16% | 47.38% | 40.38% | 46.84% | 51.93% | 51.99% | 46.92% | - |
Gross Profit | 1.03B▲ 0% | 1.25B▲ 21.6% | 1.29B▲ 3.3% | 1.99B▲ 53.9% | 2.28B▲ 14.6% | 1.76B▼ 22.8% | 1.32B▼ 24.9% | 1.32B▲ 0.0% | 1.52B▲ 14.6% | 1.49B▲ 0% |
Gross Margin % | 45.61% | 45.04% | 44.84% | 52.62% | 59.62% | 53.16% | 48.07% | 48.01% | 53.08% | 51.44% |
Gross Profit Growth % | 5.87% | 21.56% | 3.34% | 53.94% | 14.64% | -22.84% | -24.91% | 0.04% | 14.62% | - |
Operating Expenses | 724.72M | 880.27M | 887.57M | 970.72M | 941.95M | 979.61M | 922.7M | 912.14M | 1.16B | 1.13B |
OpEx % of Revenue | 32.11% | 31.69% | 30.78% | 25.66% | 24.61% | 29.58% | 33.55% | 33.11% | 40.6% | - |
Selling, General & Admin | 585.56M | 694.17M | 698.24M | 765.33M | 741.61M | 757.99M | 706.12M | 715.3M | 945.28M | 914.23M |
SG&A % of Revenue | 25.94% | 24.99% | 24.21% | 20.23% | 19.37% | 22.89% | 25.67% | 25.96% | 33.1% | - |
Research & Development | 139.16M | 186.1M | 189.34M | 205.39M | 200.34M | 221.62M | 216.58M | 196.84M | 215.84M | 220.13M |
R&D % of Revenue | 6.17% | 6.7% | 6.57% | 5.43% | 5.23% | 6.69% | 7.87% | 7.14% | 7.56% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.7M | -1000K |
Operating Income | 304.63M▲ 0% | 370.97M▲ 21.8% | 405.48M▲ 9.3% | 1.02B▲ 151.5% | 1.34B▲ 31.4% | 781.12M▼ 41.7% | 399.49M▼ 48.9% | 410.52M▲ 2.8% | 356.63M▼ 13.1% | 360.29M▲ 0% |
Operating Margin % | 13.5% | 13.35% | 14.06% | 26.96% | 35.01% | 23.59% | 14.52% | 14.9% | 12.49% | 12.41% |
Operating Income Growth % | -0.34% | 21.78% | 9.3% | 151.5% | 31.4% | -41.71% | -48.86% | 2.76% | -13.13% | - |
EBITDA | 409.63M | 551.56M | 619.51M | 1.27B | 1.65B | 1.21B | 831.26M | 838.37M | 658.9M | 773.26M |
EBITDA Margin % | 18.15% | 19.85% | 21.48% | 33.48% | 43.14% | 36.48% | 30.22% | 30.43% | 23.07% | 26.64% |
EBITDA Growth % | 0.98% | 34.65% | 12.32% | 104.4% | 30.42% | -26.84% | -31.19% | 0.86% | -21.41% | -6.39% |
D&A (Non-Cash Add-back) | 105M | 180.59M | 214.03M | 246.51M | 311.44M | 427M | 431.77M | 427.85M | 302.26M | 412.97M |
EBIT | 340.66M | 324.66M | 300.77M | 956.08M | 1.31B | 755.79M | 281.79M | 412.4M | 360.46M | 361M |
Net Interest Income | -41.37M | -65.83M | -62.13M | -48.7M | -99.89M | -100.37M | -26.68M | -23.09M | -61.08M | -66.61M |
Interest Income | 2.57M | 1.14M | 1.5M | 1.01M | 2.24M | 3.59M | 72.13M | 73.19M | 31.1M | 27.33M |
Interest Expense | 43.94M | 66.98M | 63.63M | 49.71M | 102.13M | 103.95M | 98.81M | 96.28M | 92.19M | 93.94M |
Other Income/Expense | -7.92M | -113.28M | -168.34M | -113.43M | -136.42M | -129.28M | -216.51M | -94.39M | -88.36M | -94.4M |
Pretax Income | 296.72M▲ 0% | 257.68M▼ 13.2% | 237.14M▼ 8.0% | 906.36M▲ 282.2% | 1.2B▲ 32.8% | 651.84M▼ 45.8% | 182.98M▼ 71.9% | 316.13M▲ 72.8% | 268.28M▼ 15.1% | 265.89M▲ 0% |
Pretax Margin % | 13.15% | 9.28% | 8.22% | 23.96% | 31.44% | 19.68% | 6.65% | 11.47% | 9.39% | 9.16% |
Income Tax | 139.83M | 20.21M | 9.39M | 178.27M | 314.15M | 139.16M | 3.47M | 33.05M | 25.8M | 24.19M |
Effective Tax Rate % | 47.12% | 7.84% | 3.96% | 19.67% | 26.1% | 21.35% | 1.9% | 10.46% | 9.62% | 9.1% |
Net Income | 113.02M▲ 0% | 238.79M▲ 111.3% | 227.56M▼ 4.7% | 728.1M▲ 220.0% | 943.16M▲ 29.5% | 569.18M▼ 39.7% | -118.38M▼ 120.8% | 295.83M▲ 349.9% | 241.68M▼ 18.3% | 240.96M▲ 0% |
Net Margin % | 5.01% | 8.6% | 7.89% | 19.25% | 24.64% | 17.19% | -4.3% | 10.74% | 8.46% | 8.3% |
Net Income Growth % | -51.64% | 111.28% | -4.7% | 219.96% | 29.54% | -39.65% | -120.8% | 349.91% | -18.31% | -22.36% |
Net Income (Continuing) | 156.89M | 237.47M | 227.75M | 728.1M | 889.44M | 512.68M | 179.5M | 283.07M | 242.48M | 241.53M |
Discontinued Operations | -43.87M | 1.31M | -195K | 0 | 53.72M | 56.5M | -297.88M | 12.76M | -975K | -743K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 1.02▲ 0% | 2.14▲ 110.0% | 2.04▼ 4.7% | 6.49▲ 218.2% | 8.08▲ 24.5% | 4.50▼ 44.3% | -0.95▼ 121.1% | 2.41▲ 353.9% | 2.08▼ 13.7% | 2.15▲ 0% |
EPS Growth % | -51.87% | 110% | -4.67% | 218.23% | 24.47% | -44.31% | -121.09% | 353.87% | -13.69% | -16.97% |
EPS (Basic) | 1.03 | 2.16 | 2.05 | 6.53 | 8.12 | 4.51 | -0.95 | 2.41 | 2.08 | - |
Diluted Shares Outstanding | 110.86M | 111.53M | 111.5M | 112.08M | 116.67M | 126.43M | 124.81M | 122.82M | 113.21M | 111.88M |
Basic Shares Outstanding | 109.86M | 110.56M | 110.83M | 111.51M | 116.17M | 126.16M | 124.7M | 122.76M | 113.21M | 111.88M |
Dividend Payout Ratio | 27.25% | 12.99% | 13.65% | 4.29% | 3.43% | 6.21% | - | 11.65% | 13.57% | - |
RVTY Balance Sheet
Revvity, Inc. (RVTY) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1.2B | 1.23B | 1.37B | 2.24B | 2.44B | 3.29B | 3B | 2.35B | 2.24B | 2.13B |
Cash & Short-Term Investments | 202.13M | 163.11M | 191.88M | 402.04M | 603.32M | 454.36M | 1.6B | 1.16B | 919.87M | 860.32M |
Cash Only | 202.13M | 163.11M | 191.88M | 402.04M | 603.32M | 454.36M | 913.16M | 1.16B | 919.87M | 860.32M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 689.92M | 0 | 0 | 0 |
Accounts Receivable | 552.3M | 632.67M | 725.18M | 1.16B | 707.94M | 612.78M | 632.81M | 632.4M | 744.67M | 691.38M |
Days Sales Outstanding | 89.32 | 83.13 | 91.79 | 111.46 | 67.51 | 67.54 | 83.97 | 83.78 | 95.17 | 87.32 |
Inventory | 351.68M | 338.35M | 356.94M | 514.57M | 425.89M | 405.46M | 428.06M | 367.59M | 379.5M | 387.5M |
Days Inventory Outstanding | 104.56 | 80.89 | 81.91 | 104.8 | 100.56 | 95.41 | 109.38 | 93.67 | 103.37 | 99.4 |
Other Current Assets | 93.84M | 100.51M | 100.38M | 167.21M | 703.63M | 1.82B | 337.14M | 186.22M | 195.71M | 189.11M |
Total Non-Current Assets | 4.89B | 4.74B | 5.16B | 5.72B | 12.56B | 10.84B | 10.56B | 10.04B | 9.93B | 9.87B |
Property, Plant & Equipment | 298.07M | 318.59M | 485.5M | 575.54M | 649.57M | 671.3M | 664.74M | 649.93M | 644.69M | 628.89M |
Fixed Asset Turnover | 7.57x | 8.72x | 5.94x | 6.57x | 5.89x | 4.93x | 4.14x | 4.24x | 4.43x | 4.43x |
Goodwill | 3B | 2.95B | 3.11B | 3.45B | 6.63B | 6.48B | 6.53B | 6.46B | 6.61B | 6.61B |
Intangible Assets | 1.35B | 1.2B | 1.28B | 1.37B | 3.82B | 3.38B | 3.02B | 2.64B | 2.35B | 2.31B |
Long-Term Investments | 0 | 0 | 0 | 24.66M | 110.94M | 144.62M | 0 | 124.94M | 1.16M | 1.16M |
Other Non-Current Assets | 244.3M | 270.02M | 284.17M | 308.38M | 1.35B | 166.44M | 342.97M | 163.45M | 322.32M | 322.1M |
Total Assets | 6.09B▲ 0% | 5.98B▼ 1.9% | 6.54B▲ 9.4% | 7.96B▲ 21.7% | 15B▲ 88.4% | 14.13B▼ 5.8% | 13.56B▼ 4.0% | 12.39B▼ 8.6% | 12.17B▼ 1.8% | 12B▲ 0% |
Asset Turnover | 0.37x | 0.46x | 0.44x | 0.48x | 0.26x | 0.23x | 0.20x | 0.22x | 0.23x | 0.24x |
Asset Growth % | 42.43% | -1.9% | 9.42% | 21.74% | 88.44% | -5.8% | -4% | -8.64% | -1.81% | -17.6% |
Total Current Liabilities | 950.9M | 771.63M | 762.83M | 1.65B | 1.21B | 1.54B | 1.45B | 653.1M | 1.33B | 1.24B |
Accounts Payable | 222.09M | 220.95M | 235.85M | 327.32M | 324.81M | 272.83M | 204.12M | 167.46M | 185.46M | 169.68M |
Days Payables Outstanding | 66.03 | 52.82 | 54.12 | 66.66 | 76.69 | 64.2 | 52.16 | 42.67 | 50.52 | 45.91 |
Short-Term Debt | 217.31M | 14.86M | 9.97M | 380.95M | 4.24M | 470.93M | 721.87M | 242K | 588.83M | 575.83M |
Deferred Revenue (Current) | 159.92M | 155.06M | 164.26M | 396.21M | 138.05M | 135.53M | 135.56M | 140.21M | 0 | 0 |
Other Current Liabilities | 39.46M | 44.69M | 44.52M | 47.49M | 257.79M | 324.85M | 43.28M | 44.18M | 556.95M | 493.13M |
Current Ratio | 1.26x | 1.60x | 1.80x | 1.36x | 2.01x | 2.13x | 2.07x | 3.60x | 1.68x | 1.72x |
Quick Ratio | 0.89x | 1.16x | 1.33x | 1.04x | 1.66x | 1.87x | 1.77x | 3.03x | 1.40x | 1.41x |
Cash Conversion Cycle | 127.85 | 111.19 | 119.57 | 149.59 | 91.37 | 98.75 | 141.2 | 134.78 | 148.02 | 140.82 |
Total Non-Current Liabilities | 2.64B | 2.62B | 2.96B | 2.57B | 6.65B | 5.2B | 4.24B | 4.07B | 3.59B | 3.58B |
Long-Term Debt | 1.79B | 1.88B | 2.06B | 1.61B | 4.98B | 3.92B | 3.18B | 3.15B | 2.78B | 2.77B |
Capital Lease Obligations | 0 | 0 | 146.4M | 188.4M | 147.4M | 169.97M | 132.75M | 151.5M | 148.11M | 462.88M |
Deferred Tax Liabilities | 0 | 0 | 0 | 774.53M | 1.43B | 1.11B | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 848.57M | 742.31M | 751.47M | 0 | 91.7M | 0 | 930.95M | 770.52M | 659.35M | 800.86M |
Total Liabilities | 3.59B | 3.39B | 3.72B | 4.22B | 7.86B | 6.75B | 5.69B | 4.73B | 4.92B | 4.81B |
Total Debt | 2.01B | 1.89B | 2.26B | 2.22B | 5.16B | 4.6B | 4.07B | 3.33B | 3.52B | 3.35B |
Net Debt | 1.8B | 1.73B | 2.07B | 1.82B | 4.56B | 4.14B | 3.15B | 2.16B | 2.6B | 2.49B |
Debt / Equity | 0.80x | 0.73x | 0.80x | 0.59x | 0.72x | 0.62x | 0.52x | 0.43x | 0.48x | 0.47x |
Debt / EBITDA | 4.90x | 3.43x | 3.64x | 1.75x | 3.12x | 3.80x | 4.89x | 3.97x | 5.34x | 4.33x |
Net Debt / EBITDA | 4.40x | 3.14x | 3.33x | 1.44x | 2.76x | 3.43x | 3.79x | 2.58x | 3.94x | 3.22x |
Interest Coverage | 7.75x | 4.85x | 4.73x | 19.23x | 12.79x | 7.27x | 2.85x | 4.28x | 3.91x | 3.84x |
Total Equity | 2.5B▲ 0% | 2.58B▲ 3.3% | 2.81B▲ 8.9% | 3.74B▲ 32.8% | 7.14B▲ 91.2% | 7.38B▲ 3.4% | 7.87B▲ 6.6% | 7.67B▼ 2.6% | 7.25B▼ 5.4% | 7.18B▲ 0% |
Equity Growth % | 16.23% | 3.27% | 8.85% | 32.76% | 91.17% | 3.38% | 6.64% | -2.61% | -5.43% | -22.26% |
Book Value per Share | 22.58 | 23.18 | 25.24 | 33.33 | 61.21 | 58.40 | 63.08 | 62.42 | 64.04 | 64.20 |
Total Shareholders' Equity | 2.5B | 2.58B | 2.81B | 3.74B | 7.14B | 7.38B | 7.87B | 7.67B | 7.25B | 7.18B |
Common Stock | 110.36M | 110.6M | 111.14M | 112.09M | 126.24M | 126.3M | 123.43M | 120.65M | 0 | 0 |
Retained Earnings | 2.38B | 2.6B | 2.81B | 3.51B | 4.42B | 4.95B | 5.61B | 5.85B | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -46.52M | -176.48M | -199.65M | -31.96M | -162.69M | -447.5M | -276.69M | -396.11M | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RVTY Cash Flow Statement
Revvity, Inc. (RVTY) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 288.45M | 311.04M | 363.47M | 892.18M | 1.41B | 679.81M | 91.27M | 628.3M | 581.78M | 571.23M |
Operating CF Margin % | 12.78% | 11.2% | 12.6% | 23.59% | 36.86% | 20.53% | 3.32% | 22.81% | 20.37% | - |
Operating CF Growth % | -17.73% | 7.83% | 16.86% | 145.46% | 58.12% | -51.81% | -86.57% | 588.38% | -7.4% | -26.64% |
Net Income | 156.89M | 237.47M | 227.75M | 630.56M | 889.44M | 512.68M | 179.5M | 283.07M | 241.2M | 240.96M |
Depreciation & Amortization | 105M | 180.59M | 214.03M | 201.65M | 311.44M | 427M | 431.77M | 427.85M | 405.34M | 412.97M |
Stock-Based Compensation | 25.42M | 28.77M | 31.51M | 26.9M | 29.68M | 51.52M | 41.41M | 37.81M | 22.85M | 23.83M |
Deferred Taxes | 29.04M | -51.77M | -61.78M | -30.82M | -53.4M | -107.41M | -97.48M | -110.31M | -61.48M | -61.48M |
Other Non-Cash Items | 9.77M | 46.71M | 116.61M | 215.21M | 100.61M | 58.99M | -72.58M | 8.18M | 70.65M | 58.16M |
Working Capital Changes | -37.66M | -130.73M | -164.66M | -151.32M | 132.99M | -262.97M | -391.35M | -18.3M | -96.78M | -103.2M |
Change in Receivables | -36.63M | -94.51M | -100.63M | -398.85M | 165.59M | 66.09M | -9M | -15.97M | -101.02M | -57.62M |
Change in Inventory | -17.92M | -30.18M | -9.61M | -127.36M | 32.28M | -48.63M | -14.11M | 45.09M | 14.78M | 7.43M |
Change in Payables | 34.33M | 8.9M | 7.35M | 63.23M | -7.58M | -43.8M | -76.43M | -26.02M | 7.34M | -15.25M |
Cash from Investing | -1.27B | -159.86M | -487.57M | -504.5M | -4.11B | -132.85M | 1.31B | 776.16M | -17.35M | -89.25M |
Capital Expenditures | -39.09M | -93.25M | -81.33M | -63.63M | -86.02M | -85.63M | -81.37M | -86.65M | -73.52M | -77.31M |
CapEx % of Revenue | 1.73% | 3.36% | 2.82% | 1.68% | 2.25% | 2.59% | 2.96% | 3.15% | 2.57% | 2.66% |
Acquisitions | -1.53B | -59.66M | -399.86M | -407.21M | -3.98B | 6.99M | -1.93M | 0 | 0 | -67.28M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 272.82M | 72K | 0 | -13.59M | -22.96M | -15.91M | 2.07B | 156.9M | 56.55M | 56.11M |
Cash from Financing | 782.24M | -179.23M | 150.13M | -202.87M | 2.94B | -661.8M | -947.12M | -1.13B | -855.05M | -782.75M |
Debt Issued (Net) | 822.16M | -66.04M | 208.87M | -187.47M | 3.04B | -559.17M | -517.49M | -723.07M | -521K | -471K |
Equity Issued (Net) | -3.83M | -57.45M | -6.31M | 30.73M | -47.95M | -66.52M | -388.88M | -369.58M | -817.89M | -747.98M |
Dividends Paid | -30.79M | -31.01M | -31.06M | -31.21M | -32.37M | -35.34M | -34.97M | -34.45M | -32.8M | -32.21M |
Share Repurchases | -3.83M | -57.45M | -6.31M | -6.94M | -73.07M | -80.64M | -388.88M | -369.58M | -820.82M | -753.72M |
Other Financing | -5.29M | -24.73M | -21.37M | -14.92M | -21M | -767K | -5.79M | -1.13M | -3.84M | -2.09M |
Net Change in Cash | -157.13M▲ 0% | -36.05M▲ 77.1% | 25.58M▲ 170.9% | 210.72M▲ 723.8% | 216.72M▲ 2.8% | -148.59M▼ 168.6% | 443.63M▲ 398.6% | 250.08M▼ 43.6% | -244.59M▼ 197.8% | -277.94M▲ 0% |
Free Cash Flow | 249.36M▲ 0% | 217.78M▼ 12.7% | 282.14M▲ 29.5% | 828.54M▲ 193.7% | 1.32B▲ 59.9% | 594.18M▼ 55.1% | 9.9M▼ 98.3% | 541.65M▲ 5369.0% | 508.25M▼ 6.2% | 504.75M▲ 0% |
FCF Margin % | 11.05% | 7.84% | 9.78% | 21.9% | 34.61% | 17.94% | 0.36% | 19.66% | 17.8% | 17.39% |
FCF Growth % | -21.81% | -12.66% | 29.55% | 193.67% | 59.89% | -55.15% | -98.33% | 5369.01% | -6.17% | -3.69% |
FCF per Share | 2.25 | 1.95 | 2.53 | 7.39 | 11.35 | 4.70 | 0.08 | 4.41 | 4.49 | 4.51 |
FCF Conversion (FCF/Net Income) | 2.55x | 1.30x | 1.60x | 1.23x | 1.50x | 1.19x | -0.77x | 2.12x | 2.41x | 2.09x |
Interest Paid | 35.78M | 56.45M | 82.69M | 42.14M | 54.12M | 97.93M | 94.01M | 91.09M | 0 | 0 |
Taxes Paid | 77.61M | 59.84M | 77.06M | 162.45M | 364.56M | 323.08M | 359.8M | 154.88M | 0 | 0 |
RVTY Key Ratios
Revvity, Inc. (RVTY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 4.85% | 9.39% | 8.43% | 22.23% | 17.34% | 7.84% | -1.55% | 3.81% | 3.24% | 3.28% |
Return on Invested Capital (ROIC) | 6.39% | 6.45% | 6.62% | 14.66% | 11.65% | 5.05% | 2.66% | 2.95% | 2.72% | 2.75% |
Gross Margin | 45.61% | 45.04% | 44.84% | 52.62% | 59.62% | 53.16% | 48.07% | 48.01% | 53.08% | 51.44% |
Net Margin | 5.01% | 8.6% | 7.89% | 19.25% | 24.64% | 17.19% | -4.3% | 10.74% | 8.46% | 8.3% |
Debt / Equity | 0.80x | 0.73x | 0.80x | 0.59x | 0.72x | 0.62x | 0.52x | 0.43x | 0.48x | 0.47x |
Interest Coverage | 7.75x | 4.85x | 4.73x | 19.23x | 12.79x | 7.27x | 2.85x | 4.28x | 3.91x | 3.84x |
FCF Conversion | 2.55x | 1.30x | 1.60x | 1.23x | 1.50x | 1.19x | -0.77x | 2.12x | 2.41x | 2.09x |
Revenue Growth | 6.69% | 23.08% | 3.8% | 31.18% | 1.19% | -13.48% | -16.95% | 0.16% | 3.67% | 4.78% |
Related:RVTY Dividend History·RVTY Revenue History·RVTY Price History·RVTY P/E History·RVTY Financial Ratios·RVTY Institutional Holders
RVTY SEC Filings & Documents
Revvity, Inc. (RVTY) SEC filings — annual & quarterly reports (10-K, 10-Q)
RVTY Frequently Asked Questions
Revvity, Inc. (RVTY) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Revvity, Inc. (RVTY) reported $2.90B in revenue for fiscal year 2025. This represents a 103% increase from $1.43B in 1996.
Revvity, Inc. (RVTY) grew revenue by 3.7% over the past year. Growth has been modest.
Yes, Revvity, Inc. (RVTY) is profitable, generating $241.0M in net income for fiscal year 2025 (8.5% net margin).
Dividend & Returns
Yes, Revvity, Inc. (RVTY) pays a dividend with a yield of 0.29%. This makes it attractive for income-focused investors.
Revvity, Inc. (RVTY) has a return on equity (ROE) of 3.2%. This is below average, suggesting room for improvement.
Revvity, Inc. (RVTY) generated $504.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.